Business
Exercise of Over-allotment Option
Exercise of Over-allotment Option.
About this update from Oxford Nanopore Technologies Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 5241O\n Oxford Nanopore Technologies plc\n 08 October 2021\n \n \n \n \n NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION WOULD BE UNLAWFUL. \n \n \n Neither this announcement, nor anything contained herein, shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. Investors should not subscribe for or purchase any shares referred to in this announcement except solely on the basis of the information contained in Oxford Nanopore Technologies plc's (\"Oxford Nanopore\" or the \"Company\" and, together with its subsidiaries, the \"Group\") prospectus dated 30 September 2021 (together with any supplementary prospectus, if relevant, the \"Prospectus\"), including the risk factors set out therein, that has been published by the Company in connection with the offer of ordinary shares in the Company (the \"Shares\") and the admission of such Shares to the standard listing segment of the Official List of the Financial Conduct Authority and to trading on the main market for listed securities of the London Stock Exchange plc. A copy of the Prospectus is available for inspection on the Company's website at \n https://nanoporetech.com/investors-update\n , subject to certain access restrictions.\n \n \n 8 October 2021\n \n \n \n \n \n \n \n \n \n \n \n \n \n OXFORD NANOPORE TECHNOLOGIES PLC\n \n \n \n \n \n \n Exercise of Over-allotment Option\n \n \n \n \n \n \n \n \n \n \n \n \n Further to its announcement on 4 October 2021 relating to its initial public offering (the \"Offer\") and the exercise of the over-allotment option granted by Oxford Nanopore Technologies plc (the \"Company\") to Citigroup Global Markets Limited in respect of 18,501,661 ordinary shares in the Company at the offer price of 425 pence each (the \"Over-allotment Option\"), the Company announces that 18,501,661 ordinary shares in the Company have today been admitted to the standard listing segment of the Official List of the Financial Conduct Authority and to trading on the main market for listed securities of the London Stock Exchange.\n \n \n \n \n \n Media Enquiries\n \n \n media@na...